Recently in a column I confessed to buying the penny stock of Eastgate Biotech Corp. After writing about Type 2 diabetes for 50 years, I was interested to see what would happen to the company’s momentous discovery, an oral insulin pill, instead of injections, to treat diabetes. Eastgate needs10 million dollars for a final study to satisfy Health Canada. I believed Sir Frederick Banting, who discovered insulin at the University of Toronto in 1922, would roll over in his grave as the company struggled to find financing. So, how did readers respond?
